Biocartis - Articles and news items

Study using Biocartis’ liquid biopsy assay shows new option for melanoma retreatment

Industry news / 17 March 2017 / Niamh Marriott, Junior Editor

In a new study, advanced metastatic melanoma cancer patients that had become resistant to their BRAF-targeted treatment were given a retreatment…

Biocartis and Merck partnership launch second liquid biopsy assay

Industry news / 15 March 2017 / Niamh Marriott, Junior Editor

This collaboration is aimed at jointly developing and commercialising new liquid biopsy RAS biomarker tests for metastatic colorectal cancer (mCRC)…

Biocartis launches second liquid biopsy assay

Industry news / 14 December 2016 / Niamh Louise Marriott, Digital Editor

Biocartis launched its second liquid biopsy assay, the Idylla ctKRAS Mutation Assay, which was developed in partnership with Merck…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+